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Ligand binding properties of acetylcholinesterase from Electro-
phorus electricus have been investigated under equilibrium and 
transient •state conditions with the reversible fluorescent probes, 
N-methylacridinium (N-MAC) and bis(3-aminopyridinium)-l,10-
-decane (DAP). N-MAC binds at the active site and DAP, an analog 
of decamethonium, bridges the active site and peripheral modifier 
site. The probes were used to monitor the binding of ligands that 
interact at one or both of these sites with resultant probe dis-
placement. Using a nonlinear least-squares analY'sis to reduce 
fluorescent probe displacement data, d-tubocurarine was found to 
bind at a site remote from the active site. In physiological ionic 
strength media, d-tubocurarine binds exclusively at the peripheral 
modifier site, and in low ionic strength media it binds significantly 
to both the peripheral site and active site. In both ionic ,strength 
media, the peripheral site was found to be the same site that inter-
acts with the second cationic function of bis-quaternary ammonium 
compounds like decamethonium and DAP. When d-tubocurarine 
occupies the peripheral site, the affinity of the enzyme for active 
site ligands is decreased. There is a positive correlation between 
the size of the active site ligand and the degree of d-tubocurarine 
induced destabilization suggesting steric factorn may be operative. 
Gallamine btnding is mutually exclusive with active site ligands. 
Rapid mixing stopped flow experiments were used to determine if 
this results from gallamine binding at the active site or bLnding 
at the peripheral stte with resultant conformational effects mediated 
to the active site. The demonstration of a transient gallamine--
-enzyme--N-MAC ternary complex suggests the latter binding 
pattern occurs. 
Acetylcholinesterase (AcCh-esterase)***, solubilized from choiinergic mem-
branes, may be more intimately involved in the events of synaptic transmission 
than strictly serving to hydrolyze released acetylcholine (AcCh) subsequent 
to depolarization of the post-synaptic membrane. In support of this, there have 
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been a number of reports implicating the presence of a non-catalytic ligand 
binding site on AcCh-esterase remote from the active site1- 2 , which, when 
occupied, markedly affects ligand affinity and probably catalysis at the active 
site. 
Experiments aimed at understanding the functional significance, if any, of 
the peripheral site through characterizing its specificity and interaction with 
the active site have been hindered by experimental limitations in most approa-
ches. The sole use of kinetic criteria has been complicated by the two step 
kinetic mechanism of AcCh-esterase and the preference of both sites for cationic 
ligands1-s. The application of affinity labeling9-u and n . m . r . techniques12 
have been valuable in identifying the periipheral site, but their inherent limi-
tations have prevented thorough characterization. 
In order to examine the peripheral modifier site and its interactions with 
the probes themselves h·ave been defined thorugh direct fluorimetric titration 
parameters, reversible fluorescent probes were prepared to monitor binding 
of various cholinergic ligands of interest to the two sites. Two compounds, 
N-methylacridinium (N-MAC) and bis(3-aminopyridinium)-1 ,10-decane (DAP), 
an analog of decamethonium, were found to be particularly valuable in this 
respect in studies with AcCh-esterase from ELectrophorus eLectricus4,5,i3, and 
more recently with the AcCh-receptor (14) and serum cholinesterase15. 
N-MAC OAP 
Both fluorescent probes have a strong affinity for AcCh-esterase and, 
more importantly, their intense fluorescence in aqueous solution is greatly 
quenched when bound to the enzyme surface13. The binding properties of 
the probes themselves have been defined through direct fluorimetric titration 
and inhibition kinetics. Both compounds bind to AcCh-esterase with a 1 : 1 
stoichiometry relative to the active site. N-MAC binds exclusively to the 
anionic subsite of the active site and DAP, with two cationic functions separated 
by a ten carbon alkyl chain, bridges the two sites with one cationic group 
binding at the active site and the other at the peripheral site. Since the con-
centrations of the free and bound forms of N-MAC and DAP can be measured 
in a solution containing probe and enzyme, they can serve in competitive 
equilibrium studies and transient state rapid mixing experiments to monitor 
the binding ·properties of any compound that can cause partial or total probe 
displacement. 
Using this approach, it has been possible to more clearly define the spe-
cificity of the peripheral site and its interactions with the active site. Of 
particular interest is the observation that the peripheral site, while ipreferring 
cationic ligands ·similar to those that bind at the active site, is the exclusive 
site of binding of d-tubocurarine and probably gallamine under. physiological 
ionic strength conditions. Binding to the peripheral site greatly decreases ligand 
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affinity and, perhaps, catalytic efficiency at the active site. In contrast to 
physiological ionic strength conditions, in low ionic strength media, d-tubo-
curarine binds to both the active site and peripheral site demonstrating solu-
bilized AcCh-esterase can exist in at least two functionally distinct forms in 
solution4•5• 
The equilibrium experiments involving the displacement of fluorescent 
probes from the enzyme by cholinergic ligands which, in part, lead to these 
conclusions, were examined in respect to three plausible ligand binding models 
(Table I). In the simplest scheme, model (i), the displacing ligand binds at 
TABLE I. 
Acetylcholinesterase ligand binding models assuming one fluorescent probe binding 
site and one or two displacing ligand binding sites 
Binding site of 
displacing ligand 
Fluorescent probe I 








the fluorescent probe binding site. The relationship is strictly competitive 
with binding of the two ligands mutually exclusive. Model (ii) is a partially 
competitive scheme where the displacing ligand, pr-0be and enzyme can form 
a ternary complex. This model would be applicable, for example, if the 
competing ligand bound to the peripheral site and weakened the affinity of 
N-MAC at the active site. 
Model (iii) is the most inclusive and is applicable when the competing 
ligand can bind at both a remote site and the fluorescent probe binding site. 
In this situation a ternary complex of oompetitor-probe-enzyme may form 
as well as competitor-competitor-enzyme. 
The equi1ibria involved in the three models are given below, where E is 
the enzyme, F in the fluorescent probe and D is the displacing ligand, which 
can bind at either the fluorescent probe site, D1 , or a remote site, D2 • 
Model (i) 
E+F:::::=E-F 
E + D:::::=E-D1 
Model (ii) 
E+F:::::=E-F 
E + D:::::=E-D2 
E - F + D :::::= E - F - D2 
E-D2 + F:::::=E-F-D2 
Model (iii) 
E+F:::::=E-F 
E + D:::::=E-D1 
E + D:::::=E-D2 
E- F + D :::::= E-F- D2 
E - D2 + F :::::= E - F - D2 
E-D2 + D :::::=E-D1-D2 
E-D1 + D:::::=E-D1-D2 
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The mathematical equations defining model (iii) are too complex for 
standard graphical analysis, which necessitated the use of computer-assisted 
non-linear regressions to evaluate the consistency of experimental data with 
the three models. 
Three cholinergic effectors (decamethonium, d-tubocurarine and gallamine) 
were examined as displacing 1igands using N-MAC and DAP as fluorescent 
probes in both physiological (0.1 M NaCl, 0.02 M MgCl2 , 0.01 M .phosphate, 
pH= 7.0) and low (0.001 M NaCl, 1.0 X 10-4 MgCl2, pH= 7.0) ionic strength 
media. A summary of the results is presented in Table II. Note that each of 
the models was found to be operative in at least one instance. 
TABLE II. 
Models best describing the data for N-MAC and DAP displacement by cholinergic 
ligands 
Displacing Fluorescent 
Model Best Describing Data 
Ligand Probe Physiological• 
I Strength 
Decamethonium N-MAC (i) 
DAP (i) 
Gallamine N-MAC (i) 
DAP (i) 
d-Tubocurarine N-MAC (ii) 
DAP (i) 
•Media contained 0.1 M NaCl, 0.02 M MgCt,, and 0.01 M phosphate, pH = 7.0 . 









Under physiological ionic strength conditions, decamethonium, gallamine 
and d-tubocurarine were competitive with DAP binding [model (i)] suggesting 
the binding site of each of these ligands overlaps that of DAP. Similarly, 
using N-MAC as the fluorescent probe, decamethonium and gallamine were 
competitive. However, d-tubocurarine displacement of N-MAC was most con-
sistent with model (ii) (Figure I), which requires the formation of a d-tubo-
curarine-N-MAC-enzyme complex. Since N-MAC is known to bind at the 
active site, d-tubocurarine must bind elsewhere. The location of this site is 
suggested by the DAP displacement results. Since DAP and d-tubocurarine 
are competitive, it is reasonable to conclude that d-tubocurarine binds at the 
site specific for the second cationic function on DAP. 
The destabilization of the N-MAC-enzyme complex with d-tubocurarine 
at the peripheral site is significant. A comparison of the N-MAC-enzyme 
dissociation constant in the presence and absence of d-tubocurarine shows about 
a six-fold increase when d-tubocurarine is occupying the peripheral site 
(Table III) . 
The Hgand binding parameters determined at low ionic strength differ 
both quantitatively and qualitatively from those at physiological ionic strength. 
There is a marked increase in ligand affinity at low ionic strength, consistent 
with kinetic studies and attributable to an increase in Coulombic forces. The 
binding patterns of gallamine and decamethonium remained competitive with 
both N-MAC and DAP as observed at physiological ionic strength, but d-tubo-
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curarine, rather than binding exclusively at the peripheral site, binds at both 
the peripheral site and active site. Figure 2 illustrates the data obtained from 
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-2 
Fig. 1 - d-Tubocurarine displacement of N-MAC at physiological ionic strength. Solid dots 
are the experimental points. In the regression analysis, model (iii) was reduced and became 
equivalent to model (ii). 
TABLE III. 





Low ionic strength 
(0.001) 





2.5 x 10-7 1.5 x 10-6 
1.5 x 1o·s 8.3 X 10-s 
Kd-tubocurarine/M 






•Dissociation constant for N-MAC or d-tubocurarine binding at the active site with the peri-
pheral site either unoccupied (free enzyme) or bound with d-tubocurarine (enzyme-d-tubo-
curarine). 







































/ I , 
I I 
- - - Model i 
-·- - Model ii 
-- Model iii 
OL-~~-'---~~--'-~~-'-~~-'-~~---'~~~ 
- 8 - 7 -6 - 5 -4 -3 - 2 
log ([d -Tubocurarine ]/ M) 
Fig. 2 - d-Tubocura rine displacem ent of N-MAC at low ionic strength. Solid dots represent 
experimental points , and the lines are best fits generated in non-linear regression analyses 
using the various models. 
model (iii) is the best description of the data. Both sites have strong and 
comparable affinities for d-tubocurarine. The dissociation constant at the 
active site is 4.1 X 10-1 M and at the peripheral site is slightly weaker, 
8.7 X 10-7 M. The destabilization of the N-MAC enzyme complex with d-tubo-
curarine bound at the peripheral site is similar to that observed at physiological 
ionic strength (Table III) , or about six-fold weaker in the presence of d-tubo-
curarine than in its absence. 
Similar results were obtained using DAP as the fluorescent probe. The 
data was most consistent with model (iii), permitting a d-tubocurarine-d-tubo-
curarine-enzyme complex; however, unlike the N-MAC pattern, a ternary 
complex could not form with DAP, d-tubocurarine and enzyme. This is again 
consistent with the postulate that the sites that bind the two moles of d-tubo-
curarine at low ionic strength are the same sites that interact with the two 
cationic groups on DAP. 
The effects on active site ligands caused by d-tubocurarine binding to 
the peripheral site may reflect steric factors, induced protein conformational 
changes or both. The distance between the two sites, based on the separation 
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between the cationic functions of DAP, is 14 A or less, depending on the degree 
of extension of the connecting alkyl chain. The relative affinities of compounds 
in the polymethonium series, however, suggest that decamethonium binds in 
nearly an extended conformation16• The proximity of the two sites indicates 
steric factors may be 1important since d-tubocurarine will span most of the 
distance if the bulk of the molecule is directed in the region between the 
two sites. This possibility is supported by the observation that with d-tubo-
curarine bound at the peripheral site, the destabilization of the second mo-
lecule of d-tubocurarine binding at the active site is much greater than the 
destabilization of N-MAC at the active site (Table III). If steric factors are 
significant it might be anticipated that the effects would be more significant 
when comparing the bulkier d-tubocurarine to N-MAC. 
On the other hand, ligand induced conformational changes should not be 
excluded. 0. r. d. changes have been demonstrated subsequent to 3-hydroxydi-
methylethylammonium binding to AcCh-esterase12• Many of the kinetic results 
which require a modifier site can be rationalized by steric considerations if the 
modifier site is near the active site. However, kinetic studies which demonstrate 
ligand induced effects on rates of acylation or deacylation implicate protein 
conformational changes2•3• Kitz et al.3 report gallamine can accelerate decar-
bamylation of the dimethylcarbamyl enzyme at concentrations which do not 
affect AcCh hydrolysis. Clearly, if the active site were involved in the gall-
amine induced acceleration mechanism, the rate of AcCh hydrolysis would be 
altered. These observations provide evidence that ligand binding to a remote 
site can modulate catalytic efficiency as well as ligand affinity at the active 
site. 
Although steady-state kinetic studies have indicated that .gallamine, an 
antagonist with pharmacological effects similar to d-tubocurarine, binds to a 
site remote from the active site, the results of the fluorescent probe dis-
placement experiments presented here indicate that gallamine is strictly 
competitive with N-MAC. In order to help resolve this ambiguity, the rates 
of displacement of N-MAC from the enzyme by gallamine were examined by 
stopped flow techniques. The rationale for these experiments was that the 
net displacement of N-MAC from the enzyme can proceed by the two mecha-
nisms indicated below. 
1. Competitive displacement : 











E-I-D ~ E-D +I 
k4' 
The first mechanism would be operative if the binding sites of N-MAC and 
gallamine shared a topographically identical region. If the binding site of the 
displacing ligand (D or gallamine) overlapped that of the probe (I or N-MAC) 
then the probe must dissociate prior to the binding of the displacing ligand. 
When conditions are used which assure that binding of the displacing ligand 
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is not rate limiting, the rate of dissociation of fluorescent probe will be k1 , 
or the off-rate characteristic of the enzyme-probe binary complex. The latter 
rate constant can be determined independently. 
The second mechanism would be expected if the binding site of the probe 
and displacing ligand do not overlap. In this case, a transient ternary complex 
of probe-enzyme-displacing ligand will form, and the probe dissociates from 
a ternary complex. This rate should be different from the rate of dissociation 
from the binary complex. 
The results of experiments using several cholinergic ligands to displace 
N-MAC from the active site are reported in Table IV. The half-lives for the 
TABLE IV. 
Rates of Displacement of N-Methylacridinium ion from acetylcholinesterasea 
Displacing Ligand Concentration/M Half Life/ms 
Choline chloride 5.0 x 10-3 5.7 
Decamethonium 5.0 x 10"6 6.7 
2.5 x 10-5 7.5 
d-Tubocurarine 5.0 x 10-5 26.1 
2.5 x 10-4 44.0 
Atropine 5.0 x 10-3 21.5 
Gallamine 7.5 x 10-5 12.8 
•Media contained 0.001 M phosphate, pH ~ 7.0, 25 •c. 
displacement of N-MAC by known active site ligands, such as decamethonium 
and choline, are equal to the half-life of N-MAC dissociation from the binary 
complex determined independently in rapid dilution experiments. This impli-
cates mechanism 1, since the dissociation of N-MAC must occur prior to the 
binding of the displacing ligand. On the other hand, the rate of N-MAC 
displacement by d-tubocurarine and atropine is significantly slower than that 
observed for active site ligands. These results are consistent with the mecha-
nism requiring prior ternary complex formation. Gallamine also shows a rate 
which is 1perturbed relative to that observed for active site ligands, suggesting 
it can form a ternary complex with enzyme and N-MAC even though the 
complex is unstable and not detectable by equilibrium methods. Therefore, 
transient state kinetics have demonstrated that gallamine and N-MAC, which 
appear competitive under equilibriium conditions, have topogrnphically distinct 
sites, and that gallamine, like d-tubocurarine, binds at a site remote from the 
active site. 
The effects at the active site resulting from gallamine binding to the 
peripheral site are clearly significant. In contrast to d-tubocurarine, no ternary 
complex of N-MAC- enzyme-displacing ligand is detectable with gallamine at 
equilibrium. The destabilization of the active site ligand, N-MAC, appears 
to be at least an order of magnitude greater when gallamine is occupying 
the peripheral site compared to d-tubocurarine. 
In summary, the application of N-MAC and DAP to monitor binding at 
the various ligand binding site on AcCh-esterase under equilibrium and trans-
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ient state condition has lead to the clear identification of a ligand binding site 
approximately 14 A from the active site. The remote site has a unique 
specificity and prefers large polycationic ligands like d-tubocurarine, atropine 
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Fig. 3 - Schematic representation of acety lcholinesterase ligand binding topography with 
decamethonium and d-tubocurarine bound under physiological and low ionic strength 
conditions. 
site and peripheral site can be demonstrated. When the peripheral site is 
occupied, there is a resultant decrease in ligand affinity and possibly catalytic 
efficiency at the active site. Interestingly, the enzyme can exist in two ionic 
strength dependent forms as judged by d-tubocurarine binding. Under physio-
logical ionic strength conditions AcCh-esterase binds d-tubocurarine exclusively 
at the peripheral site, while under low ionic strength conditions, there is 
significant binding at both the cationic site and peripheral site. The form of 
the enzyme which most accurately approximated the membrane bound enzyme 
remains to be determined. 
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DISCUSSION 
P. W. Taylor: 
I was surprised that the half-life of N-methylacridinium diss.ociation was still 
changing at 2.5 X 10-• M d-tubocurarine s1nce the K 0 for d-tubocurarine in the 
ternary complex is 2 X 10-7 M. Have you measured -the concentration dependence 
of d - tubocurarine-induced dissociation? 
G. Mooser: 
The dissociation constant for d-tubocurarine binding to the peripheral site 
on the free enzyme is about 8 X 10-7 M, but in the stopped flow experiments we 
are dealing with the formation of the d-tubocurarine-enzyme-N-MAC ternary 
complex where the dissociation constant ·is about 5 X 10·6 M. In the regression 
analysis the determination of these constants is not as accurate as those for the 
binary complexes and may be off by a factor .of 2 or so. However, 1n this range 
it might be expected that the d-tubocurarine displacement of N-MAC would reach 
its maximum effects at 2.5 X 10-4 M, but not necessarily at 5 X 10·5 M. Another 
possibility suggested to me by Dr. Rosenberry is d-tubocurarine may form an 
initial weak complex with the enzyme which is subsequently stabilized in a slower 
step. We, of course, cannot distinguish these possibilities without examining the 
effects of d-tubocurarine over a wider range of concentrations. 
SAZETAK 
Interakcija mjesta za vezivanje liganada na kolinesterazu 
G. Mooser i D. S. Sigman 
Istrafona su svojstva acetilkolinesteraze vrste Electrophorus electricus s obzi-
rom na vezivanje liganada u ravnoteznomu i u prijelaznim stanjima uporabom 
reversibilnih fluorescentnih spojeva, N-metilakridinija (N-MAC) i bis(3-amino-piri-
dinium)-1 ,10-dekana (DAP) . N-MAC se veze u aktivnom mjestu, a DAP, analog deka-
metonija, povezuje poput mosta aktivno mjesto i periferno n ekataliticko mjesto. 
Tim spojevima praceno je vezivanje liganada, koji reagiraju s jednim iLi s oba ova 
mjesta, na osnovi zamjene. Primjenom nelinearne regresije u pokusima zamjene 
Eluorescentnih spojeva, utvrdeno je da se d-tubokurarin vezuje za mjesto udaljeno 
od katalitickoga. Pri fizioloskoj ionskoj jakosti medija, d-tubokurarin se veze isklju-
civo na periferno nekataliticko mjesto a uz nisku ionsku jakost medij a veze se na 
oba, i na periferno i na kataliticko mjesto. Uz obje ionske jakosti medija nadeno je, 
da je per<iferno nekataliticko mjesto vezivanja ono isto, koje reagira sa sekundar-
nom kationskom funkcijom bis- kvarternih amonijevih spojeva, kao sto su dekame-
tonij i DAP. Kad je periferno mjesto zauzeto d-tubokurarinom, afinitet enzima za 
vezivanje liganada u aktivnom mjestu je smanjen. Pozit<ivna korelacija izmedu veli-
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cme liganada za aktivno mjesto i stupnja inducirane destabilizacije d-tubokura-
rinom, upucuje na mogucnost djelovanja nekih sterickih faktora. Reakcije vezivanja 
galamina i liganada u aktivno mjesto medusobno se iskljueuju. Spektrofotometrij-
skom metodom zaustavljenog toka istrafono je, da li je to posljedica vezivanja gala-
mina u samom aktivnom mjestu ili se galamin vefo na perHerno nekataliticko 
mjesto, sto uzrokuje konformacijske promjene u samom aktivnom mjestu. Posto-
janje jednoga prijelaznog ternarnog kompleksa: galamin-enzim-N-MAC, upub;je na 
to, da je vjerojatnije vezivanje galamina na periferno mjesto. 
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